Jennifer S. Lam

499 total citations
9 papers, 405 citations indexed

About

Jennifer S. Lam is a scholar working on Immunology, Infectious Diseases and Oncology. According to data from OpenAlex, Jennifer S. Lam has authored 9 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 2 papers in Infectious Diseases and 2 papers in Oncology. Recurrent topics in Jennifer S. Lam's work include Antifungal resistance and susceptibility (2 papers), Psoriasis: Treatment and Pathogenesis (2 papers) and Immunotherapy and Immune Responses (2 papers). Jennifer S. Lam is often cited by papers focused on Antifungal resistance and susceptibility (2 papers), Psoriasis: Treatment and Pathogenesis (2 papers) and Immunotherapy and Immune Responses (2 papers). Jennifer S. Lam collaborates with scholars based in United States, Australia and Canada. Jennifer S. Lam's co-authors include Stuart M. Levitz, Lauren E. Yauch, Michael K. Mansour, Charles A. Specht, Haibin Huang, Annalisa D’Andrea, Jianmin Chen, F Yin, Ying Ying Yiu and Timothy J. Mitchell and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and PLoS Pathogens.

In The Last Decade

Jennifer S. Lam

8 papers receiving 400 citations

Peers

Countries citing papers authored by Jennifer S. Lam

Since Specialization

Citations

This map shows the geographic impact of Jennifer S. Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer S. Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer S. Lam more than expected).

Fields of papers citing papers by Jennifer S. Lam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer S. Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer S. Lam. The network helps show where Jennifer S. Lam may publish in the future.

Co-authorship network of co-authors of Jennifer S. Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer S. Lam. A scholar is included among the top collaborators of Jennifer S. Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer S. Lam. Jennifer S. Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Hysteroscopic Endometrial Resection in Women Treated With Tamoxifen for Breast Cancer Provides Definitive Diagnosis and Effective Long-Term Therapy 2021 ·Journal of Obstetrics and Gynaecology Canada ·George A. Vilos, (unknown), (unknown), Jennifer S. Lam, Ahmad Badeghiesh, Basim Abu‐Rafea, Angelos G. Vilos	2
2	Inhibition of TYK2 and JAK1 Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis by Inhibiting IL-22 and the IL-23/IL-17 Axis 2014 ·The Journal of Immunology ·Melissa Works, F Yin, Catherine Yin, Ying Ying Yiu, (unknown), (unknown), (unknown), Jennifer S. Lam, Timothy J. Mitchell, (unknown), Paula Stein, Annalisa D’Andrea	81
3	Nociceptin/orphanin FQ inhibition with SB612111 ameliorates dextran sodium sulfate-induced colitis 2012 ·European Journal of Pharmacology ·Carsten Alt, Jennifer S. Lam, Mike T. Harrison, Kathleen M. Kershaw, Steven J. Samuelsson, Lawrence Toll, Annalisa D’Andrea	25
4	Diamino-1,2,4-triazole derivatives are selective inhibitors of TYK2 and JAK1 over JAK2 and JAK3 2010 ·Bioorganic & Medicinal Chemistry Letters ·Jeremiah P. Malerich, Jennifer S. Lam, Barry Hart, Richard Fine, Boris Klebansky, Mary J. Tanga, Annalisa D’Andrea	29
5	SR16951, a new small molecule antagonist of MCP-1 for the treatment of autoimmune diseases (50.13) 2009 ·The Journal of Immunology ·Jennifer S. Lam, Carsten Alt, Claude C.A. Bernard, Edgardo Laborde, Annalisa D’Andrea	0
6	Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines 2007 ·Vaccine ·(unknown), Jennifer S. Lam, Jianmin Chen, Stuart M. Levitz	43
7	Effect of Differential N-linked and O-linked Mannosylation on Recognition of Fungal Antigens by Dendritic Cells 2007 ·PLoS ONE ·Jennifer S. Lam, Haibin Huang, Stuart M. Levitz	47
8	Direct Inhibition of T-Cell Responses by the Cryptococcus Capsular Polysaccharide Glucuronoxylomannan 2006 ·PLoS Pathogens ·Lauren E. Yauch, Jennifer S. Lam, Stuart M. Levitz	92
9	A Model Vaccine Exploiting Fungal Mannosylation to Increase Antigen Immunogenicity 2005 ·The Journal of Immunology ·Jennifer S. Lam, Michael K. Mansour, Charles A. Specht, Stuart M. Levitz	86

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact